21 CFR Part 11 enables the use of electronic records and signatures in FDA-regulated environments while ensuring data integrity, security, and traceability. It applies to systems that manage electronic records and outlines requirements for closed and open systems, emphasizing validation, access control, and documentation. Compliance resources and further training opportunities are suggested for understanding and implementing these requirements.